Neoleukin Therapeutics, Inc.
(NASDAQ CM: NLTX)
Rigrodsky Law, P.A. is investigating Neoleukin Therapeutics, Inc. (“Neoleukin”) regarding possible breaches of fiduciary duties and other violations of law related to Neoleukin’s agreement to merge with Neurogene Inc.